BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 27595760)

  • 21. CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type.
    Wang L; Wang H; Li PF; Lu Y; Xia ZJ; Huang HQ; Zhang YJ
    Ann Hematol; 2015 Aug; 94(8):1381-8. PubMed ID: 25865943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
    Lee WJ; Moon IJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
    Int J Dermatol; 2019 Jun; 58(6):688-696. PubMed ID: 30597548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
    Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
    Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
    Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
    Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer/T-cell lymphoma.
    Lim SW; Ryu KJ; Lee H; Ko YH; Kim WS; Kim SJ
    Leuk Lymphoma; 2019 Feb; 60(2):317-325. PubMed ID: 29979096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis with MEDA chemotherapy.
    Li DH; Zhang XY; Du C; Zhang WH; Chang J; Ma YJ; Li ZC; Hao SG; Ding H; Tao R
    Leuk Lymphoma; 2017 May; 58(5):1238-1241. PubMed ID: 27658861
    [No Abstract]   [Full Text] [Related]  

  • 27. Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type.
    Cho HJ; Jang MS; Hong SD; Kim SJ; Ahn YC; Oh D; Ko YH; Kim HY; Dhong HJ; Chung SK; Kim WS
    Int Forum Allergy Rhinol; 2015 Oct; 5(10):960-6. PubMed ID: 26039707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome.
    Li N; Jiang M; Wu WC; Wei WW; Zou LQ
    Front Oncol; 2021; 11():704962. PubMed ID: 34490105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
    Varelas AN; Ganti A; Eggerstedt M; Tajudeen BA
    Laryngoscope; 2019 Dec; 129(12):2675-2680. PubMed ID: 30801751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemophagocytic syndrome associated NK/T nasal type lymphoma presenting as hypereosinophilic syndrome: a case report and literature review.
    Romero Fernández E; Pardo JR; Doyle A; Albendea MC; de la Rúa AR
    Leuk Res; 2011 Jul; 35(7):e97-9. PubMed ID: 21501869
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prognostic factors of nasal NK/T-cell lymphoma].
    Ma Q; Zhang HL; Liu X; Zhou SY; Qian ZZ; Zhai QL; Fu K; Wang HQ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Dec; 48(12):1011-6. PubMed ID: 24507001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type.
    Yong W; Zheng W; Zhu J; Zhang Y; Wang X; Xie Y; Lin N; Xu B; Lu A; Li J
    Ann Hematol; 2009 Jul; 88(7):647-52. PubMed ID: 19107482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
    Suzuki R; Suzumiya J; Yamaguchi M; Nakamura S; Kameoka J; Kojima H; Abe M; Kinoshita T; Yoshino T; Iwatsuki K; Kagami Y; Tsuzuki T; Kurokawa M; Ito K; Kawa K; Oshimi K;
    Ann Oncol; 2010 May; 21(5):1032-40. PubMed ID: 19850638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Li P; Jiang L; Zhang X; Liu J; Wang H
    BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
    Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
    Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.
    Li ZM; Zhu YJ; Sun J; Xia Y; Huang JJ; Zou BY; Lin TY; Huang HQ; Jiang WQ
    Ann Hematol; 2012 Aug; 91(8):1265-70. PubMed ID: 22373550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
    Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
    Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD.
    Kato T; Tanabe J; Kanemoto M; Kobayashi C; Morita S; Karahashi T
    Mod Rheumatol; 2009; 19(6):675-80. PubMed ID: 19609486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients.
    Kim SJ; Park S; Kang ES; Choi JY; Lim DH; Ko YH; Kim WS
    Ann Hematol; 2015 Jan; 94(1):71-8. PubMed ID: 25082384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
    Wang H; Li P; Wang L; Xia Z; Huang H; Lu Y; Li Z
    Ann Hematol; 2015 Sep; 94(9):1535-44. PubMed ID: 25990795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.